Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 26 Oct 2017
At a glance
- Drugs Prasugrel (Primary) ; Aspirin
- Indications Coronary thrombosis
- Focus Therapeutic Use
- 19 Oct 2017 Planned number of patients changed from 120 to 84.
- 19 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.